- Home
- MSEX vs KOD Comparison
MSEX vs KOD Comparison
Compare MSEX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | KOD |
|---|---|---|
| Founded | 1897 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.9M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MSEX | KOD |
|---|---|---|
| Price | $53.24 | $24.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $59.25 | $22.67 |
| AVG Volume (30 Days) | 145.5K | ★ 720.6K |
| Earning Date | 10-31-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | ★ 3.71 | N/A |
| EPS | ★ 2.39 | N/A |
| Revenue | ★ $194,822,000.00 | N/A |
| Revenue This Year | $3.92 | N/A |
| Revenue Next Year | $8.51 | N/A |
| P/E Ratio | $22.24 | ★ N/A |
| Revenue Growth | ★ 6.24 | N/A |
| 52 Week Low | $44.17 | $1.92 |
| 52 Week High | $67.09 | $26.21 |
Technical Indicators
Market Signals| Indicator | MSEX | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 60.32 |
| Support Level | $51.55 | $21.24 |
| Resistance Level | $53.77 | $24.97 |
| Average True Range (ATR) | 1.58 | 1.70 |
| MACD | 0.47 | -0.16 |
| Stochastic Oscillator | 90.00 | 62.58 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.